Kezar Life Sciences (NASDAQ: KZR) Faces Setback as US FDA Puts Lupus Drug Trial on Hold
The U.S. Food and Drug Administration has placed a clinical hold on Kezar Life Sciences’ (NASDAQ: KZR) trial of an […]
Kezar Life Sciences (NASDAQ: KZR) Faces Setback as US FDA Puts Lupus Drug Trial on Hold Read More »
